Doctor’s Blog
Dr. Goodman, panelist, 2020 Annual APSARD conference January 12, Washington DC
Dr. David W. Goodman has been invited as a panelist to discuss clinical implications of adult ADHD research and the use of medications in complex treatment. APSARD, American Professional Society for ADHD and Related Disorders, is a nationally and internationally represented professional organization devoted to the advancement of ADHD education, research, and treatment. I have […]
Dr. David W. Goodman, a featured speaker at the NYU Conference on Adult ADHD December 7, 2019
NYU Langone Health conference on Adult ADHD will feature international experts Dr. Len Adler, Dr. Joseph Beiderman, Dr. Francisco X. Castellanos and others. I am honored to be invited as faculty to present the latest science on ADHD in older adults (over the age of 50). My presentation will cover topics of identification and diagnosis […]
Vayarin for ADHD no longer sold in the U.S.
This month Enzymotec, the makers of Vayarin, quietly announced on their website that they would no longer sell its product in the U.S. This leaves patients who have been taking it in a quandary without support. While the company’s announcement cites “a lack of alignment with our business strategy” as an explanation, no one gives […]
NBC News interviews Dr. David W. Goodman for the new study on stimulants for ADHD and psychosis risk. March 21, 2019
Stimulants for ADHD and risk of psychosis has been a clinical concern but the risk has thought to be quite low. Dr. Goodman’s comments about the study can be read here. The recent New England Journal of Medicine study has demonstrated the risk of psychosis with amphetamines is 0.2% and methylphenidate is 0.1%. These findings […]
Dr. Goodman interviewed for Today.com on ADHD parents
Parenting an ADHD child is challenging. Yet, this challenge is heightened when one or both of the parents have ADHD. While consistent behavioral routines are advocated in ADHD households, untreated ADHD parents will have great difficulty executing consistent oversight of their children. from Today.com reviewed a video of a family whose has ADHD and wanted […]
CVS Carmark Medication Authorization Criteria January 1, 2018
CVS CAREMARK CRITERIA Starting January 1, 2018, these patients may not be able to fill their current medication at the pharmacy, based on the plan’s coverage changes. Please visit caremark.com/highvalueplan to review the coverage details of this pharmacy benefit plan. PA = Prior Authorization There must be a satisfied PA on file […]
We now know why your mental health insurance coverage comes up short!
UnitedHealthCare/Optum were cited by the court to have created internally generated algorithms for mental health care that fell short of acceptable standards for professional psychiatric associations. Your frustration from inadequate coverage now has a reason. Read the following details from the Psychiatric News March 7, 2019. UBH Found to Have Wrongfully Denied Care Using Flawed […]
Dr. David W. Goodman on CHADD Webinar Ask the Expert April 18, 2019 at 2pm LIVE
“What can I expect as an adult from my ADHD treatment in the first 6 months?” I have been invited to speak online LIVE for the Children and Adults with ADHD Association Webinar Series “Ask the Expert”. I will discuss the benefits of ADHD treatment as they unfold over the first 6 months of treatment. […]
ADDitude Magazine Webinar ADHD in Older Adults David W. Goodman, MD
On May 1, 2018 I presented the first webinar for ADDitude Magazine on ADHD in adults over the age 50. The presentation with audio and slides is available to be hear for free. This is a rare discussion of prevalence, diagnosis, impairments, and treatment of older adults. Complaints of cognitive symptoms are common in older […]
Dr. David W. Goodman invited to speak at the Neuroscience Education Institute in Las Vegas, April 2020
A faculty speaker for the Neuroscience Education Institute (NEI) for many years, I have been invited to present several talks on adult ADHD and the complexity of medications. There are currently 28 different ADHD stimulant preparations (my last count). While there are only 4 different chemical compounds (methylphenidate, d-methylphenidate, amphetamine, d-amphetamine), the technologies delivering medication […]